 |
|
|
| |
Preclinical Pharmacokinetic Assessment of a Long-acting Solid Injectable for Hepatitis C Virus
|
| |
| |
CROI 2025 SF March 9-12
Usman Arshad1,3, Henry Pertinez1,3, Joanne Sharp1,3, Helen Cox1,3, Joanne Herriott1,3, Edyta Kijak1,3, Eduardo Gallardo-Toledo1,3, Jonathan Massam2,3, Andrew B. Dwyer2,3, Alison Savage2,3, James J. Hobson2,3, Catherine Unsworth2,3, David L. Thomas4, Paul Curley1,3, Steve P. Rannard2,3, Andrew Owen1,3
1Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, UK, 2Department of Chemistry, University of Liverpool, UK, 3Centre of Excellence for Long-acting Therapeutics (CELT), University of Liverpool, UK, 4Department of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
|
| |
|
|
|
|
|
